Public Dashboard: Morningstar 4 Bargains (9/11/2020)
These undervalued wide-moat stocks earn low uncertainty ratings. -- Susan Dziubinski
09/16/2025 | ||||||||||||
Company | Symbol | Shares | Price | Value | % of Total | Growth | Proj P/E | Proj Yield | Fin Str | EPS Stab | Qlty | PAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Averages | $550.34 | 3.5% | 14.2 | 2.6% | 54% | 61 | 63.8 | 8.3% | ||||
Coca-Cola | KO | 1.96 | $66.21 | $129.67 | 23.6% | 4.6% | 22.4 | 3.0% | 82% | 100 | 93 | 10.0% |
Novartis | NVS | 1.11 | $123.31 | $137.19 | 24.9% | 5.5% | 17.7 | 3.1% | 76% | 61 | 86 | 8.6% |
Pfizer | PFE | 2.77 | $23.97 | $66.45 | 12.1% | 2.2% | 10.3 | 4.6% | 49% | 56 | 59 | 12.5% |
Roche Holdings* | RHHBY | 2.21 | $40.97 | $90.56 | 16.5% | 4.9% | 19.8 | 3.5% | 60% | 95 | 82 | 14.0% |
Vanguard Total Stock Market | VTSMX | 1.22 | $104.05 | $126.46 | 23.0% | 0.0% | 0.0 | 0.0% | 0% | 0 | 0 | -0.1% |